Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program Pharmaceutical Investing
Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer Pharmaceutical Investing
Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program Pharmaceutical Investing
Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE (palbociclib) and talazoparib in Combination with CB-839 Biotech Investing
Isodiol International Inc. Subsidiary, BSPG Laboratories LTD., Launches API Sales and Marketing Program at CPhI 2018 Cannabis Investing News
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares Biotech Investing
Adamas Announces Publication of Data Demonstrating Dyskinesia’s Impact on Activities of Daily Living in People with Parkinson’s Disease Pharmaceutical Investing
IntelGenx Partner Insud Pharma Submits ANDA for Co-Developed Generic Buccal Film Product Pharmaceutical Investing
SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease Pharmaceutical Investing
